Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 249-256

  Maeder, Micha T ^a,b,c   Kaye, David M ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Blood pressure; Ejection fraction; Heart failure; Heart rate; Pulse pressure

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84857040383     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.007     Document Type: Article

References (35)

1. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
2. W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: Prediction of survival in heart failure Circulation 113 2006 1424 1433
3. K. Fox, I. Ford, P.G. Steg, M. Tendera, M. Robertson, and R. Ferrari Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
4. D.M. Kaye, and H. Krum Drug discovery for heart failure: A new era or the end of the pipeline? Nat Rev Drug Discov 6 2007 127 139
5. D.M. Kaye, J. Lefkovits, G.L. Jennings, P. Bergin, A. Broughton, and M.D. Esler Adverse consequences of high sympathetic nervous activity in the failing human heart J Am Coll Cardiol 26 1995 1257 1263
6. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved trial Lancet 362 2003 777 781
7. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
8. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
9. B.M. Massie, P.E. Carson, and J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
10. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
11. R.S. Vasan, and D. Levy Defining diastolic heart failure: a call for standardized diagnostic criteria Circulation 101 2000 2118 2121
12. A. Ahmed, M.W. Rich, and J.L. Fleg Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary digitalis investigation group trial Circulation 114 2006 397 403
13. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney function-measured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
14. M. Ahmadi-Kashani, D.J. Kessler, and J. Day Heart rate predicts outcomes in an implantable cardioverter-defibrillator population Circulation 120 2009 2040 2045
15. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, and P.W. Armstrong Meta-analysis: Beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
16. K. Fox, I. Ford, P.G. Steg, M. Tendera, and R. Ferrari Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
17. G.P. Aurigemma, and W.H. Gaasch Clinical practice. Diastolic heart failure N Engl J Med 351 2004 1097 1105
18. D.M. Kaye, D. Mansfield, A. Aggarwal, M.T. Naughton, and M.D. Esler Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure Circulation 103 2001 2336 2338
19. D.M. Kaye, G.W. Lambert, J. Lefkovits, M. Morris, G. Jennings, and M.D. Esler Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure J Am Coll Cardiol 23 1994 570 578
20. M.P. Schlaich, D.M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M.D. Esler Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 2003 560 565
21. V. Melenovsky, B.A. Borlaug, and B. Rosen Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: The role of atrial remodeling/dysfunction J Am Coll Cardiol 49 2007 198 207
22. S. Kasama, T. Toyama, and H. Kumakura Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction J Am Coll Cardiol 45 2005 661 667
23. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
24. A. Ahmed, M.R. Zile, and M.W. Rich Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure Am J Cardiol 99 2007 460 464
25. M.T. Maeder, and D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
26. D.J. van Veldhuisen, A. Cohen-Solal, and M. Bohm Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
27. S. Cook, M. Togni, M.C. Schaub, P. Wenaweser, and O.M. Hess High heart rate: A cardiovascular risk factor? Eur Heart J 27 2006 2387 9233
28. D.M. Henkel, M.M. Redfield, S.A. Weston, Y. Gerber, and V.L. Roger Death in heart failure: A community perspective Circ Heart Fail 1 2008 91 97
29. Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction: Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation; 121:1393-1405.
30. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
31. S.J. Pocock, D. Wang, and M.A. Pfeffer Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75
32. F.H. Messerli, and G.S. Panjrath The J-curve between blood pressure and coronary artery disease or essential hypertension: Exactly how essential? J Am Coll Cardiol 54 2009 1827 1834
33. R.C. Jones, G.S. Francis, and M.S. Lauer Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial J Am Coll Cardiol 44 2004 1025 1029
34. L.G. Olsson, K. Swedberg, and A. Ducharme Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program J Am Coll Cardiol 47 2006 1997 2004
35. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150